Drugs / PX
last change Mar 2026 re-read 2 minutes ago

PX

Developed for
peritoneum cancer
Investigated by
Peking University · Shenzhen Bay Laboratory

Trials 1 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT07454031 Mar → Dec 2026 expected peritoneum cancer Peking University Not yet recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as PX ClinicalTrials.gov intervention name — accepted as the source's own label NCT07454031